Clinical Trial Detail

NCT ID NCT02428712
Title A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Plexxikon
Indications

Advanced Solid Tumor

thyroid gland carcinoma

melanoma

Therapies

PLX8394

Age Groups: adult senior child

Additional content available in CKB BOOST